Bradford J. Crutchfield's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 286 Class A Common Stock done at an average price of $48.8 . Disclosure was reported to the exchange on May 23, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 48.77 per share. | 23 May 2022 | 286 | 97,237 (0%) | 0% | 48.8 | 13,947 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 40.49 per share. | 13 May 2022 | 158 | 97,523 (0%) | 0% | 40.5 | 6,397 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 78.60 per share. | 22 Feb 2022 | 288 | 97,365 (0%) | 0% | 78.6 | 22,637 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 95.13 per share. | 15 Feb 2022 | 17,000 | 97,653 (0%) | 0% | 95.1 | 1,617,261 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 17,000 | 392,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 15 Feb 2022 | 17,000 | 114,653 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2022 | 17,000 | 409,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 12 Jan 2022 | 17,000 | 114,653 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 117.53 per share. | 12 Jan 2022 | 6,195 | 108,458 (0%) | 0% | 117.5 | 728,071 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 118.32 per share. | 12 Jan 2022 | 5,185 | 103,273 (0%) | 0% | 118.3 | 613,499 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 121.76 per share. | 12 Jan 2022 | 3,200 | 97,956 (0%) | 0% | 121.8 | 389,648 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 120.93 per share. | 12 Jan 2022 | 1,100 | 101,156 (0%) | 0% | 120.9 | 133,025 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 119.28 per share. | 12 Jan 2022 | 1,017 | 102,256 (0%) | 0% | 119.3 | 121,311 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 124.44 per share. | 12 Jan 2022 | 100 | 97,656 (0%) | 0% | 124.4 | 12,444 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 123.53 per share. | 12 Jan 2022 | 100 | 97,756 (0%) | 0% | 123.5 | 12,353 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 122.94 per share. | 12 Jan 2022 | 100 | 97,856 (0%) | 0% | 122.9 | 12,294 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 12 Jan 2022 | 3 | 97,653 (0%) | 0% | 125 | 375 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 21 Dec 2021 | 49,910 | 97,653 (0%) | 0% | 5.0 | 251,546 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 49,910 | 61,757 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 21 Dec 2021 | 4,688 | 47,743 (0%) | 0% | 1.2 | 5,626 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 4,688 | 0 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 13 Dec 2021 | 17,000 | 60,055 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2021 | 17,000 | 426,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 139.52 per share. | 13 Dec 2021 | 9,599 | 45,656 (0%) | 0% | 139.5 | 1,339,239 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 138.60 per share. | 13 Dec 2021 | 3,235 | 55,255 (0%) | 0% | 138.6 | 448,374 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 140.38 per share. | 13 Dec 2021 | 1,701 | 43,955 (0%) | 0% | 140.4 | 238,792 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 137.63 per share. | 13 Dec 2021 | 1,565 | 58,490 (0%) | 0% | 137.6 | 215,396 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 141.31 per share. | 13 Dec 2021 | 800 | 43,155 (0%) | 0% | 141.3 | 113,049 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 142.47 per share. | 13 Dec 2021 | 100 | 43,055 (0%) | 0% | 142.5 | 14,247 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 148.38 per share. | 22 Nov 2021 | 281 | 43,055 (0%) | 0% | 148.4 | 41,695 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 12 Nov 2021 | 17,000 | 60,336 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 17,000 | 443,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 164.87 per share. | 12 Nov 2021 | 6,872 | 48,312 (0%) | 0% | 164.9 | 1,132,963 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 165.89 per share. | 12 Nov 2021 | 4,776 | 43,536 (0%) | 0% | 165.9 | 792,306 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 164.18 per share. | 12 Nov 2021 | 4,122 | 55,184 (0%) | 0% | 164.2 | 676,733 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 163.10 per share. | 12 Nov 2021 | 1,030 | 59,306 (0%) | 0% | 163.1 | 167,994 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 168.34 per share. | 12 Nov 2021 | 100 | 43,336 (0%) | 0% | 168.3 | 16,834 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 167.27 per share. | 12 Nov 2021 | 100 | 43,436 (0%) | 0% | 167.3 | 16,727 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 12 Oct 2021 | 17,000 | 60,336 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2021 | 17,000 | 460,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 157.40 per share. | 12 Oct 2021 | 7,997 | 46,379 (0%) | 0% | 157.4 | 1,258,760 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 156.49 per share. | 12 Oct 2021 | 5,960 | 54,376 (0%) | 0% | 156.5 | 932,678 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 158.63 per share. | 12 Oct 2021 | 3,043 | 43,336 (0%) | 0% | 158.6 | 482,716 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 17,000 | 477,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 13 Sep 2021 | 17,000 | 60,336 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 176.19 per share. | 13 Sep 2021 | 3,906 | 46,736 (0%) | 0% | 176.2 | 688,198 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 174.14 per share. | 13 Sep 2021 | 2,700 | 53,336 (0%) | 0% | 174.1 | 470,166 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 175.17 per share. | 13 Sep 2021 | 2,694 | 50,642 (0%) | 0% | 175.2 | 471,900 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 169.06 per share. | 13 Sep 2021 | 2,300 | 58,036 (0%) | 0% | 169.1 | 388,834 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 177.21 per share. | 13 Sep 2021 | 1,700 | 45,036 (0%) | 0% | 177.2 | 301,259 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 170.30 per share. | 13 Sep 2021 | 1,300 | 56,736 (0%) | 0% | 170.3 | 221,394 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 178.24 per share. | 13 Sep 2021 | 1,000 | 44,036 (0%) | 0% | 178.2 | 178,237 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 178.90 per share. | 13 Sep 2021 | 500 | 43,536 (0%) | 0% | 178.9 | 89,451 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 172.40 per share. | 13 Sep 2021 | 400 | 56,036 (0%) | 0% | 172.4 | 68,958 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 171.20 per share. | 13 Sep 2021 | 300 | 56,436 (0%) | 0% | 171.2 | 51,361 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 184.32 per share. | 13 Sep 2021 | 100 | 43,336 (0%) | 0% | 184.3 | 18,432 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 181.24 per share. | 13 Sep 2021 | 100 | 43,436 (0%) | 0% | 181.2 | 18,124 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 161.85 per share. | 23 Aug 2021 | 270 | 43,336 (0%) | 0% | 161.8 | 43,699 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2021 | 17,000 | 494,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 12 Aug 2021 | 17,000 | 60,606 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 161.28 per share. | 12 Aug 2021 | 5,087 | 44,406 (0%) | 0% | 161.3 | 820,436 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 12 Aug 2021 | 3,400 | 49,493 (0%) | 0% | 160.0 | 544,011 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 159.13 per share. | 12 Aug 2021 | 3,213 | 52,893 (0%) | 0% | 159.1 | 511,290 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 158.07 per share. | 12 Aug 2021 | 2,400 | 56,106 (0%) | 0% | 158.1 | 379,374 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 157.19 per share. | 12 Aug 2021 | 2,100 | 58,506 (0%) | 0% | 157.2 | 330,100 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 161.84 per share. | 12 Aug 2021 | 800 | 43,606 (0%) | 0% | 161.8 | 129,472 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 12 Jul 2021 | 17,000 | 60,606 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2021 | 17,000 | 511,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 185.07 per share. | 12 Jul 2021 | 5,755 | 54,851 (0%) | 0% | 185.1 | 1,065,097 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 185.87 per share. | 12 Jul 2021 | 4,400 | 50,451 (0%) | 0% | 185.9 | 817,811 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 187.31 per share. | 12 Jul 2021 | 3,933 | 46,518 (0%) | 0% | 187.3 | 736,674 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 188.32 per share. | 12 Jul 2021 | 1,512 | 45,006 (0%) | 0% | 188.3 | 284,733 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 190.86 per share. | 12 Jul 2021 | 600 | 43,906 (0%) | 0% | 190.9 | 114,518 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 189.36 per share. | 12 Jul 2021 | 500 | 44,506 (0%) | 0% | 189.4 | 94,682 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 191.60 per share. | 12 Jul 2021 | 300 | 43,606 (0%) | 0% | 191.6 | 57,481 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 14 Jun 2021 | 17,000 | 60,262 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2021 | 17,000 | 528,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 192.97 per share. | 14 Jun 2021 | 5,100 | 43,662 (0%) | 0% | 193.0 | 984,128 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 192.12 per share. | 14 Jun 2021 | 4,500 | 48,762 (0%) | 0% | 192.1 | 864,535 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 190.01 per share. | 14 Jun 2021 | 3,084 | 56,262 (0%) | 0% | 190.0 | 585,995 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 191.16 per share. | 14 Jun 2021 | 3,000 | 53,262 (0%) | 0% | 191.2 | 573,476 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 189.03 per share. | 14 Jun 2021 | 916 | 59,346 (0%) | 0% | 189.0 | 173,147 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 193.64 per share. | 14 Jun 2021 | 400 | 43,262 (0%) | 0% | 193.6 | 77,456 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 17,000 | 545,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 12 May 2021 | 17,000 | 51,608 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 134.70 per share. | 12 May 2021 | 7,875 | 38,610 (0%) | 0% | 134.7 | 1,060,759 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 133.86 per share. | 12 May 2021 | 5,123 | 46,485 (0%) | 0% | 133.9 | 685,759 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 135.74 per share. | 12 May 2021 | 2,702 | 35,908 (0%) | 0% | 135.7 | 366,781 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 136.80 per share. | 12 May 2021 | 1,200 | 34,708 (0%) | 0% | 136.8 | 164,164 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 137.57 per share. | 12 May 2021 | 100 | 34,608 (0%) | 0% | 137.6 | 13,757 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2021 | 17,000 | 562,000 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 12 Apr 2021 | 17,000 | 51,608 (0%) | 0% | 1.2 | 19,720 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 186.31 per share. | 12 Apr 2021 | 2,855 | 41,802 (0%) | 0% | 186.3 | 531,911 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 181.84 per share. | 12 Apr 2021 | 2,642 | 48,059 (0%) | 0% | 181.8 | 480,426 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 188.36 per share. | 12 Apr 2021 | 2,398 | 37,408 (0%) | 0% | 188.4 | 451,695 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 187.10 per share. | 12 Apr 2021 | 1,996 | 39,806 (0%) | 0% | 187.1 | 373,450 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 185.14 per share. | 12 Apr 2021 | 1,500 | 44,657 (0%) | 0% | 185.1 | 277,714 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 189.34 per share. | 12 Apr 2021 | 1,400 | 36,008 (0%) | 0% | 189.3 | 265,075 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 182.75 per share. | 12 Apr 2021 | 1,302 | 46,757 (0%) | 0% | 182.7 | 237,938 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 190.31 per share. | 12 Apr 2021 | 1,100 | 34,908 (0%) | 0% | 190.3 | 209,340 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Bradford J. Crutchfield | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 181.10 per share. | 12 Apr 2021 | 907 | 50,701 (0%) | 0% | 181.1 | 164,260 | Class A Common Stock |